Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Neuronetics, Inc. Director's Dealing 2025

Feb 26, 2025

33660_dirs_2025-02-26_81e3dbf1-f532-4807-9c98-1f760c567c83.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuronetics, Inc. (STIM)
CIK: 0001227636
Period of Report: 2025-02-24

Reporting Person: MACAN WILLIAM ANDREW (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-24 Common Stock A 157500 Acquired 527182 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-24 Performance Restricted Stock Unit $0 A 78750 Acquired 2028-07-01 Common Stock (78750) Direct

Footnotes

F1: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 24, 2026, in each case subject to continuous service of the Reporting Person through such date.

F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F3: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock.

F4: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027.